 |
Book by July 31 to Enjoy Savings and Bonus Coupons on Hong Kong – Seoul Flights
HONG KONG, July 18, 2025 /PRNewswire/ -- T'way Air, Korea's leading low-cost carrier, has launched its "Summer Vacation Deals" promotion on its website. Valid through July 31, the offer applies to Hong Kong–Incheon (Seoul) flights for travel through March 28, 2026.
T'way Air operates daily flights between Hong Kong and Incheon (Seoul) using A330-200 and A330-300 aircraft. Flight departs Hong Kong at 12:40 a.m. arriving in Seoul at 5:30 a.m. local time, while return flights leave Incheon at 8:05 p.m. and land in Hong Kong at 11:15 p.m. The A330-300 offers enhanced comfort with 12 flat-bed Business Saver seats with extra legroom, power outlets and reading lights, ensuring more relaxed journey for travelers.
T'way Air offers three limited-time coupons through July 31:
- HKD 140 Off Coupon: valid on bookings of HKD 1,400 or more, travel through March 28, 2026.
- HKD 80 Off Coupon: valid on bookings of HKD 800 or more, travel through March 28, 2026.
- HKD 200 Early Bird Coupon: valid on bookings of HKD 1,400 or more, travel period September 1 – March 28, 2026.
Plus, passengers entering promo code VACAY12 at booking will save up to 12% (actual savings vary with the exchange rate at purchase).
From sizzling street food at Gwangjang Market to the timeless beauty of Changdeokgung Palace, Seoul offers a vibrant mix of culture, history, and flavor that captivates every traveler. Down south, Busan's laid-back beach vibe and Jeju Island's quiet natural beauty offer a refreshing summer retreat. Whether you are a foodie, a history lover, or a k-pop enthusiast, South Korea welcomes travelers with open arms.
For full flight schedules, coupon terms, and booking details, visit twayair.com. T'way Air currently serves 60 destinations worldwide and continues to expand its network.
About T'way Air
T'way Air Co., Ltd., headquartered in Daegu, South Korea, is a leading low-cost carrier (LCC) providing affordable and reliable air travel since 2010. T'way Air serves customers across East Asia, Southeast Asia, Central Asia, Oceania, and Europe with a modern fleet of Boeing 737-800s, 737 MAX 8s, and Airbus A330s, and Boeing 777-300ERs. T'way Air continues to expand its global network, offering great value to passengers worldwide. For more information, please visit www.twayair.com.
Media Contact
T'WAY AIR Public Relations
twaypr@twayair.com
Book by July 31 to Enjoy Savings and Bonus Coupons on Hong Kong – Seoul Flights
HONG KONG, July 18, 2025 /PRNewswire/ -- T'way Air, Korea's leading low-cost carrier, has launched its "Summer Vacation Deals" promotion on its website. Valid through July 31, the offer applies to Hong Kong–Incheon (Seoul) flights for travel through March 28, 2026.
T'way Air operates daily flights between Hong Kong and Incheon (Seoul) using A330-200 and A330-300 aircraft. Flight departs Hong Kong at 12:40 a.m. arriving in Seoul at 5:30 a.m. local time, while return flights leave Incheon at 8:05 p.m. and land in Hong Kong at 11:15 p.m. The A330-300 offers enhanced comfort with 12 flat-bed Business Saver seats with extra legroom, power outlets and reading lights, ensuring more relaxed journey for travelers.
T'way Air offers three limited-time coupons through July 31:
- HKD 140 Off Coupon: valid on bookings of HKD 1,400 or more, travel through March 28, 2026.
- HKD 80 Off Coupon: valid on bookings of HKD 800 or more, travel through March 28, 2026.
- HKD 200 Early Bird Coupon: valid on bookings of HKD 1,400 or more, travel period September 1 – March 28, 2026.
Plus, passengers entering promo code VACAY12 at booking will save up to 12% (actual savings vary with the exchange rate at purchase).
From sizzling street food at Gwangjang Market to the timeless beauty of Changdeokgung Palace, Seoul offers a vibrant mix of culture, history, and flavor that captivates every traveler. Down south, Busan's laid-back beach vibe and Jeju Island's quiet natural beauty offer a refreshing summer retreat. Whether you are a foodie, a history lover, or a k-pop enthusiast, South Korea welcomes travelers with open arms.
For full flight schedules, coupon terms, and booking details, visit twayair.com. T'way Air currently serves 60 destinations worldwide and continues to expand its network.
About T'way Air
T'way Air Co., Ltd., headquartered in Daegu, South Korea, is a leading low-cost carrier (LCC) providing affordable and reliable air travel since 2010. T'way Air serves customers across East Asia, Southeast Asia, Central Asia, Oceania, and Europe with a modern fleet of Boeing 737-800s, 737 MAX 8s, and Airbus A330s, and Boeing 777-300ERs. T'way Air continues to expand its global network, offering great value to passengers worldwide. For more information, please visit www.twayair.com.
Media Contact
T'WAY AIR Public Relations
twaypr@twayair.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Fly to Korea with T'way Air's Summer Vacation Deals from Hong Kong
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
